Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,076
Closed -$316K 200
2026
Q1
$316K Sell
3,076
-171
-5% -$19.3K 0.12% 118
2025
Q4
$407K Sell
3,247
-1,035
-24% -$132K 0.17% 104
2025
Q3
$574K Sell
4,282
-3
-0.1% -$394 0.26% 67
2025
Q2
$583K Sell
4,285
-21
-0.5% -$2.77K 0.31% 55
2025
Q1
$571K Buy
4,306
+663
+18% +$84.4K 0.32% 56
2024
Q4
$412K Buy
3,643
+1,592
+78% +$184K 0.23% 74
2024
Q3
$234K Buy
+2,051
New +$225K 0.12% 115
2024
Q1
Sell
-3,076
Closed -$339K 135
2023
Q4
$339K Buy
+3,076
New +$307K 0.17% 74

Other funds holding ABT

Traveka Wealth's ABT Position: Q2 2026 in Review

Traveka Wealth sold out of Abbott (ABT) in Q2 2026, closing a stake of 3,076 shares — an estimated $316K sold.

Traveka Wealth first reported a position in ABT in Q4 2023 and held it in 8 quarters. The position peaked at $583K in Q2 2025. 1,464 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Traveka Wealth reported no remaining Abbott position as of Q2 2026 after selling out during the quarter.
  • Traveka Wealth sold 3,076 Abbott shares in Q2 2026, an estimated $316K.
  • Traveka Wealth first reported a position in Abbott in Q4 2023 and held it in 8 quarters.
  • Traveka Wealth's Abbott position peaked at $583K in Q2 2025.
  • 1,464 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Traveka Wealth's 13F filing for Q2 2026, filed 21 Jul 2026.